Correlation Between Sarofim Equity and Us Strategic

Can any of the company-specific risk be diversified away by investing in both Sarofim Equity and Us Strategic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarofim Equity and Us Strategic into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sarofim Equity and Us Strategic Equity, you can compare the effects of market volatilities on Sarofim Equity and Us Strategic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarofim Equity with a short position of Us Strategic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarofim Equity and Us Strategic.

Diversification Opportunities for Sarofim Equity and Us Strategic

0.67

Correlation Coefficient

Sarofim Equity  Us Strategic

Poor diversification

The 3 months correlation between Sarofim and RUSTX is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Sarofim Equity and Us Strategic Equity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Us Strategic Equity and Sarofim Equity is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarofim Equity are associated (or correlated) with Us Strategic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Us Strategic Equity has no effect on the direction of Sarofim Equity i.e., Sarofim Equity and Us Strategic go up and down completely randomly.

Pair Corralation between Sarofim Equity and Us Strategic

Assuming the 90 days horizon Sarofim Equity is expected to under-perform the Us Strategic. In addition to that, Sarofim Equity is 1.16 times more volatile than Us Strategic Equity. It trades about -0.13 of its total potential returns per unit of risk. Us Strategic Equity is currently generating about -0.12 per unit of volatility. If you would invest  1,885  in Us Strategic Equity on November 29, 2024 and sell it today you would lose (225.00) from holding Us Strategic Equity or give up 11.94% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Sarofim Equity  vs.  Us Strategic Equity

Sarofim Equity

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sarofim Equity has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's primary indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Us Strategic Equity

Risk-Adjusted Performance

Very Weak

Over the last 90 days Us Strategic Equity has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Pair Trading with Sarofim Equity and Us Strategic

The main advantage of trading using opposite Sarofim Equity and Us Strategic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarofim Equity position performs unexpectedly, Us Strategic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Us Strategic will offset losses from the drop in Us Strategic's long position.

The idea behind Sarofim Equity and Us Strategic Equity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..